Cannabis Science and Technology® is pleased to announce the addition of André Silva, MSc Forensic Science to its editorial advisory board (EAB).
André Silva graduated in 2018 with a master’s degree in Forensic Science from Anglia Ruskin University in Cambridge, England where he also worked as an Associate Lecturer. He is currently a Field Marketing Specialist for Reference Materials for Merck.
Silva previously worked as a portfolio specialist for the same group of products, supporting customers in Spain and Portugal at both a technical and commercial level. He has also been involved in multiple initiatives around the cannabis testing industry on topics ranging from laboratory quality control to regulatory and legal matters.
To maximize his free time, Silva fills his schedule with sports, literature, podcasts, travelling, and any hobbies that spark his curiosity.
Welcome to the board, André Silva!
Cannabis Science and Technology® also recently announced several other new members to its EAB:
For a complete list of the Cannabis Science and Technology® Editorial Advisory Board please visit: www.cannabissciencetech.com/cannabis-science-and-technology-editorial-advisory-board.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.